114 related articles for article (PubMed ID: 32277689)
1. Targeting caspase - dependent apoptosis in hepatocellular carcinoma.
Niotis A; Petrogiannopoulos L; Niotis T; Tsiambas E
J BUON; 2020; 25(1):583. PubMed ID: 32277689
[No Abstract] [Full Text] [Related]
2. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
Liu Y; Sun L; Su X; Guo S
Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K analog (compound 5) induces apoptosis in human hepatocellular carcinoma independent of the caspase pathway.
Enokimura N; Shiraki K; Kawakita T; Saitou Y; Inoue H; Okano H; Yamamoto N; Sugimoto K; Carr BI; Nakano T
Anticancer Drugs; 2005 Sep; 16(8):837-44. PubMed ID: 16096431
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy.
Schuchmann M; Schulze-Bergkamen H; Fleischer B; Schattenberg JM; Siebler J; Weinmann A; Teufel A; Wörns M; Fischer T; Strand S; Lohse AW; Galle PR
Oncol Rep; 2006 Jan; 15(1):227-30. PubMed ID: 16328060
[TBL] [Abstract][Full Text] [Related]
5. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated transfection of caspase-8 sensitizes hepatocellular carcinoma to TRAIL- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Nakano T
Biochim Biophys Acta; 2006 Aug; 1763(8):844-53. PubMed ID: 16750275
[TBL] [Abstract][Full Text] [Related]
7. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
8. The novel carboxamide analog ITR-284 induces caspase-dependent apoptotic cell death in human hepatocellular and colorectal cancer cells.
Liao YR; Lu CC; Lai KC; Yang JS; Kuo SC; Wen YF; Fushiya S; Wu TS
Mol Med Rep; 2013 May; 7(5):1539-44. PubMed ID: 23468003
[TBL] [Abstract][Full Text] [Related]
9. Cordycepol C induces caspase-independent apoptosis in human hepatocellular carcinoma HepG2 cells.
Sun YS; Lv LX; Zhao Z; He X; You L; Liu JK; Li YQ
Biol Pharm Bull; 2014; 37(4):608-17. PubMed ID: 24694607
[TBL] [Abstract][Full Text] [Related]
10. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
[TBL] [Abstract][Full Text] [Related]
11. Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells.
Im E; Yeo C; Lee EO
Life Sci; 2018 Sep; 209():259-266. PubMed ID: 30107166
[TBL] [Abstract][Full Text] [Related]
12. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro.
Chen YL; Yan MY; Chien SY; Kuo SJ; Chen DR; Cheng CY; Su CC
Mol Med Rep; 2013 May; 7(5):1487-93. PubMed ID: 23525225
[TBL] [Abstract][Full Text] [Related]
13. Sulindac induces apoptosis, inhibits proliferation and activates caspase-3 in Hep G2 cells.
Liu JJ; Wang JY; Hertervig E; Nilsson A; Duan RD
Anticancer Res; 2002; 22(1A):263-6. PubMed ID: 12017300
[TBL] [Abstract][Full Text] [Related]
14. The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells.
Ocker M; Alajati A; Ganslmayer M; Zopf S; Lüders M; Neureiter D; Hahn EG; Schuppan D; Herold C
J Cancer Res Clin Oncol; 2005 Jun; 131(6):385-94. PubMed ID: 15754201
[TBL] [Abstract][Full Text] [Related]
15. The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin.
Lu Y; Cederbaum A
Free Radic Biol Med; 2007 Oct; 43(7):1061-75. PubMed ID: 17761302
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.
Lee N; Kwon JH; Kim YB; Kim SH; Park SJ; Xu W; Jung HY; Kim KT; Wang HJ; Choi KY
Oncotarget; 2015 Oct; 6(30):30130-48. PubMed ID: 26375549
[TBL] [Abstract][Full Text] [Related]
17. [Role of caspase-8 and caspase-3 in hepatoma cells apoptosis induced by 5-fluorouracil].
Yang LY; Yi TB; Lu J; Yang JQ
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):314, 317. PubMed ID: 12773255
[No Abstract] [Full Text] [Related]
18. The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis.
Okano J; Nagahara T; Matsumoto K; Murawaki Y
Oncol Rep; 2007 May; 17(5):1195-200. PubMed ID: 17390065
[TBL] [Abstract][Full Text] [Related]
19. Blazeispirol A from Agaricus blazei fermentation product induces cell death in human hepatoma Hep 3B cells through caspase-dependent and caspase-independent pathways.
Su ZY; Tung YC; Hwang LS; Sheen LY
J Agric Food Chem; 2011 May; 59(9):5109-16. PubMed ID: 21417302
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibitory effects of celecoxib and fluvastatin on the growth of human hepatocellular carcinoma xenografts in nude mice.
Gao J; Jia WD; Li JS; Wang W; Xu GL; Ma JL; Ge YS; Yu JH; Ren WH; Liu WB; Zhang CH
J Int Med Res; 2010; 38(4):1413-27. PubMed ID: 20926014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
